Liver resection for hepatocellular carcinoma

Daria Zorzi; Jean Nicolas Vauthey; Eddie K. Abdalla

doi:10.1007/978-1-60327-522-4_9

Liver resection for hepatocellular carcinoma

Daria Zorzi, Jean Nicolas Vauthey, Eddie K. Abdalla

Surgical Oncology

Research output: Chapter in Book/Report/Conference proceeding › Chapter

2 Scopus citations

Abstract

The natural history of untreated HCC varies depending on the stage at presentation and the degree of underlying liver disease. However, even in patients with early stages, the prognosis is poor if the disease is left untreated [1, 2]. As primary medical therapy has failed to significantly improve survival, surgical resection and orthotopic liver transplantation (OLT) represent the only treatment options offering a prospect for cure with 5-year survival rates of up to 50% [3-5] and 70% [6, 7], respectively.

Original language	English (US)
Title of host publication	Hepatocellular Carcinoma
Subtitle of host publication	Targeted Therapy and Multidisciplinary Care
Publisher	Springer New York
Pages	109-134
Number of pages	26
ISBN (Print)	9781603275217
DOIs	https://doi.org/10.1007/978-1-60327-522-4_9
State	Published - 2011

Keywords

Child-Pugh (CP) classification
Fibrolamellar carcinoma (FLHCC)
Future liver remnant
HCC preoperative therapy
HCC surgical resection
Liver resection
Metabolic assessment
Multinodular HCC
Orthotopic liver transplantation

ASJC Scopus subject areas

General Medicine

Access to Document

10.1007/978-1-60327-522-4_9

Cite this

@inbook{40ab79d5032a410ba1a04f45d07abd91,

title = "Liver resection for hepatocellular carcinoma",

abstract = "The natural history of untreated HCC varies depending on the stage at presentation and the degree of underlying liver disease. However, even in patients with early stages, the prognosis is poor if the disease is left untreated [1, 2]. As primary medical therapy has failed to significantly improve survival, surgical resection and orthotopic liver transplantation (OLT) represent the only treatment options offering a prospect for cure with 5-year survival rates of up to 50% [3-5] and 70% [6, 7], respectively.",

keywords = "Child-Pugh (CP) classification, Fibrolamellar carcinoma (FLHCC), Future liver remnant, HCC preoperative therapy, HCC surgical resection, Liver resection, Metabolic assessment, Multinodular HCC, Orthotopic liver transplantation",

author = "Daria Zorzi and Vauthey, {Jean Nicolas} and Abdalla, {Eddie K.}",

year = "2011",

doi = "10.1007/978-1-60327-522-4_9",

language = "English (US)",

isbn = "9781603275217",

pages = "109--134",

booktitle = "Hepatocellular Carcinoma",

publisher = "Springer New York",

}

TY - CHAP

T1 - Liver resection for hepatocellular carcinoma

AU - Zorzi, Daria

AU - Vauthey, Jean Nicolas

AU - Abdalla, Eddie K.

PY - 2011

Y1 - 2011

N2 - The natural history of untreated HCC varies depending on the stage at presentation and the degree of underlying liver disease. However, even in patients with early stages, the prognosis is poor if the disease is left untreated [1, 2]. As primary medical therapy has failed to significantly improve survival, surgical resection and orthotopic liver transplantation (OLT) represent the only treatment options offering a prospect for cure with 5-year survival rates of up to 50% [3-5] and 70% [6, 7], respectively.

AB - The natural history of untreated HCC varies depending on the stage at presentation and the degree of underlying liver disease. However, even in patients with early stages, the prognosis is poor if the disease is left untreated [1, 2]. As primary medical therapy has failed to significantly improve survival, surgical resection and orthotopic liver transplantation (OLT) represent the only treatment options offering a prospect for cure with 5-year survival rates of up to 50% [3-5] and 70% [6, 7], respectively.

KW - Child-Pugh (CP) classification

KW - Fibrolamellar carcinoma (FLHCC)

KW - Future liver remnant

KW - HCC preoperative therapy

KW - HCC surgical resection

KW - Liver resection

KW - Metabolic assessment

KW - Multinodular HCC

KW - Orthotopic liver transplantation

UR - http://www.scopus.com/inward/record.url?scp=84862509213&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862509213&partnerID=8YFLogxK

U2 - 10.1007/978-1-60327-522-4_9

DO - 10.1007/978-1-60327-522-4_9

M3 - Chapter

AN - SCOPUS:84862509213

SN - 9781603275217

SP - 109

EP - 134

BT - Hepatocellular Carcinoma

PB - Springer New York

ER -

Liver resection for hepatocellular carcinoma

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this